Recorded Webinar: Standardized Assays for Personalized Immune Response Monitoring
If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. This onlin...
Biomarkers for a new cancer immunotherapy drug
This month's paper features the results of a Phase I study on a new cancer immunotherapy drug. VTX-2337 is a toll-like receptor 8 agonist, activating...
A New Generation of Biomarkers for Detecting Early Signs of Kidney Damage
Nephrotoxicity is a major problem in the preclinical and clinical setting that results in the failure of candidate compounds throughout the drug-devel...
Establishing the boundaries of a healthy immune response
New research published in Immunity describes a standardized method to reproducibly measure a functional immune response in healthy donors. Conducted b...
Biomarkers Validated for Acute Kidney Injury (AKI)
A clinical test measuring tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 (IGFBP7) in urine has been...
Recorded Webinar: Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue using Myriad RBM’s Multiplex ApoptosisMAP™
If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. View Recor...
How to use multiplexed immunoassays in inflammatory diseases
Chronic inflammatory processes are associated with a remarkable range of human diseases including numerous cardiovascular, pulmonary, neurodegenerativ...